ARTICLE | Clinical News
Decitabine modulator of DNA methylation regulatory update
March 10, 2003 8:00 AM UTC
The EMEA granted SUPG's European affiliate, EuroGen Pharmaceuticals Ltd., Orphan Medicinal Product designation for SUPG's Decitabine to treat myelodysplastic syndrome (MDS). Decitabine is in Phase III...